First Turn Management »

Rocket Pharmaceuticals shares owned by First Turn Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.8M 251k 26.94

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Rocket Pharmaceuticals

Wellington Management Company
BlackRock
Vanguard Group
Westfield Capital Management Company
Maverick Capital
T. Rowe Price Associates
Henderson Group
Citadel Advisors
Franklin Resources
Perceptive Advisors
Frazier Life Sciences Management
Geode Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Logos Global Management

View all funds holding Rocket Pharmaceuticals